Ovid Therapeutics Inc. Common Stock (OVID) is a biopharmaceutical company that develops therapies to treat rare neurological disorders. With a focus on precision medicine, Ovid’s innovative approach aims to deliver meaningful outcomes for patients and their families. Its pipeline includes potential treatments for Fragile X syndrome, Angelman syndrome, and other neurological conditions.
